TONEfitSUN Sebum Control Vegan Sunscreen Stick

Manufacturer
Hankook Cosmetics Manufacturing Co.,Ltd_Eumseong Factory | HANKOOK COSMETICS CO., LTD.
Effective date
2026-04-27
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:55:07

Label at a glance#

ProductTONEfitSUN Sebum Control Vegan Sunscreen
Active ingredientOCTOCRYLENE, AVOBENZONE, HOMOSALATE, OCTISALATE
Label structure9 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients

Avobenzone 2.7%
Homosalate 13.5%
Octisalate 4.5%
Octocrylene 9.5%

OTC - PURPOSE SECTION

Purpose
Sunscreen

INDICATIONS & USAGE SECTION

Uses

• helps prevent sunburn

• if used as directed with other sun protection measures ( see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

WARNINGS SECTION

Warnings
For external use only
Do not use• on damaged or broken skin
When using this product• keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if• rash occurs
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions
• apply liberally 15 minutes before sun exposure
• children under 6 months of age : Ask a doctor
• reapply at least every 2 hours
• use a water resistant sunscreen if swimming or sweating
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection
measures including:
• limit time in the sun, especially from 10 a.m.- 2 p.m.
• wear long-sleeved shirts, pants, hats, and sunglasses

OTHER SAFETY INFORMATION

Other Information
• Protect this product from excessive heat and direct sun

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

INACTIVE INGREDIENT SECTION

Inactive Ingredients

Dibutyl Adipate, Butyloctyl Salicylate, Vinyl Dimethicone/Methicone Silsesquioxane Crosspolymer, Silica, Synthetic Wax, C12-15 Alkyl Benzoate, Polyester-8, Butylene Glycol Dicaprylate/Dicaprate, VP/Hexadecene Copolymer, Synthetic Fluorphlogopite, Microcrystalline Wax, 1,2-Hexanediol, Caprylic/Capric Glycerides, Fragrance(Parfum), Triethoxycaprylylsilane, Tocopheryl Acetate, Panthenol

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Carton ImageCarton Image

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58544-160-01TONEfitSUN Sebum Control Vegan Sunscreen20 g in 1 CONTAINERSTICK201
58544-160-02TONEfitSUN Sebum Control Vegan Sunscreen1 in 1 CARTONSTICK11

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
58544-16058544-160-01, 58544-160-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TONEfitSUN Sebum Control Vegan SunscreenAVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENEHankook Cosmetics Manufacturing Co.,Ltd_Eumseong Factory506b96ae-eb2a-edad-e063-6294a90a470e2026-04-27WarningsExact identifier
ndc (package): 58544-160-02
ndc (package): 58544-160-01
ndc (product): 58544-160
ndc11 (package): 58544016001
ndc11 (package): 58544016002
spl id: 506b8ae9-30a9-7e7e-e063-6394a90aa9eb
spl set id: 506b96ae-eb2a-edad-e063-6294a90a470e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.